Sign in or register to see full information and data.

Studies / CAVD 287


Study information

Grant Affiliation:Ho: Enhancing Innate Immune Activation
Strategy:Prophylactic neutralizing Ab
Study Type:Antibody Screening
Species:Non-Organism Study
Stage:Assays Completed
Study Start Date:2003-12-18
Study Made Public:2011-02-25


Screen for broadly neutralizing sera among the Aaron Diamond AIDS Research Center HIV+ Patient Cohort in New York City [Original Study Title: HIV Controllers]


CAVD 287 is an immunogenicity study to evaluate and characterize the neutralization activity of broadly neutralizing antibodies in HIV controllers.


No Products used in study

Integrated data

No integrated data is available for this study.

Non-integrated data

No non-integrated data is available for this study.